vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and FIRST HORIZON CORP (FHN). Click either name above to swap in a different company.
FIRST HORIZON CORP is the larger business by last-quarter revenue ($888.0M vs $829.0M, roughly 1.1× Acadia Healthcare Company, Inc.). FIRST HORIZON CORP runs the higher net margin — 29.4% vs 0.5%, a 28.9% gap on every dollar of revenue. On growth, FIRST HORIZON CORP posted the faster year-over-year revenue change (21.8% vs 7.5%). Over the past eight quarters, FIRST HORIZON CORP's revenue compounded faster (20.0% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
ACHC vs FHN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $888.0M |
| Net Profit | $4.5M | $261.0M |
| Gross Margin | — | — |
| Operating Margin | — | 38.5% |
| Net Margin | 0.5% | 29.4% |
| Revenue YoY | 7.5% | 21.8% |
| Net Profit YoY | -50.8% | 57.2% |
| EPS (diluted) | $0.05 | $0.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $888.0M | ||
| Q3 25 | $851.6M | $889.0M | ||
| Q2 25 | $869.2M | $830.0M | ||
| Q1 25 | $770.5M | $812.0M | ||
| Q4 24 | $774.2M | $729.0M | ||
| Q3 24 | $815.6M | $827.0M | ||
| Q2 24 | $796.0M | — |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $261.0M | ||
| Q3 25 | $36.2M | $262.0M | ||
| Q2 25 | $30.1M | $241.0M | ||
| Q1 25 | $8.4M | $218.0M | ||
| Q4 24 | $32.6M | $166.0M | ||
| Q3 24 | $68.1M | $218.0M | ||
| Q2 24 | $78.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 38.5% | ||
| Q3 25 | 4.7% | 38.7% | ||
| Q2 25 | 5.8% | 37.2% | ||
| Q1 25 | 1.7% | 35.1% | ||
| Q4 24 | 4.9% | 28.8% | ||
| Q3 24 | 12.1% | 34.0% | ||
| Q2 24 | 13.4% | — |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 29.4% | ||
| Q3 25 | 4.3% | 29.5% | ||
| Q2 25 | 3.5% | 29.0% | ||
| Q1 25 | 1.1% | 26.8% | ||
| Q4 24 | 4.2% | 22.8% | ||
| Q3 24 | 8.4% | 26.4% | ||
| Q2 24 | 9.9% | — |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.51 | ||
| Q3 25 | $0.40 | $0.50 | ||
| Q2 25 | $0.33 | $0.45 | ||
| Q1 25 | $0.09 | $0.41 | ||
| Q4 24 | $0.36 | $0.29 | ||
| Q3 24 | $0.74 | $0.40 | ||
| Q2 24 | $0.85 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $8.8B |
| Total Assets | $5.5B | $83.9B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $8.8B | ||
| Q3 25 | $3.1B | $8.9B | ||
| Q2 25 | $3.1B | $9.0B | ||
| Q1 25 | $3.0B | $8.7B | ||
| Q4 24 | $3.1B | $8.8B | ||
| Q3 24 | $3.0B | $9.0B | ||
| Q2 24 | $3.0B | — |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $83.9B | ||
| Q3 25 | $6.4B | $83.2B | ||
| Q2 25 | $6.3B | $82.1B | ||
| Q1 25 | $6.1B | $81.5B | ||
| Q4 24 | $6.0B | $82.2B | ||
| Q3 24 | $5.9B | $82.6B | ||
| Q2 24 | $5.7B | — |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $396.0M |
| Free Cash FlowOCF − Capex | — | $389.0M |
| FCF MarginFCF / Revenue | — | 43.8% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | 13.78× | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $595.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $396.0M | ||
| Q3 25 | $73.2M | $-200.0M | ||
| Q2 25 | $133.5M | $83.0M | ||
| Q1 25 | $11.5M | $349.0M | ||
| Q4 24 | $116.7M | $191.0M | ||
| Q3 24 | $163.1M | $389.0M | ||
| Q2 24 | $171.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $389.0M | ||
| Q3 25 | $-63.0M | $-208.0M | ||
| Q2 25 | $-34.2M | $74.0M | ||
| Q1 25 | $-163.2M | $340.0M | ||
| Q4 24 | $-86.8M | $174.0M | ||
| Q3 24 | $-27.1M | $383.0M | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 43.8% | ||
| Q3 25 | -7.4% | -23.4% | ||
| Q2 25 | -3.9% | 8.9% | ||
| Q1 25 | -21.2% | 41.9% | ||
| Q4 24 | -11.2% | 23.9% | ||
| Q3 24 | -3.3% | 46.3% | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.8% | ||
| Q3 25 | 16.0% | 0.9% | ||
| Q2 25 | 19.3% | 1.1% | ||
| Q1 25 | 22.7% | 1.1% | ||
| Q4 24 | 26.3% | 2.3% | ||
| Q3 24 | 23.3% | 0.7% | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.52× | ||
| Q3 25 | 2.02× | -0.76× | ||
| Q2 25 | 4.43× | 0.34× | ||
| Q1 25 | 1.37× | 1.60× | ||
| Q4 24 | 3.58× | 1.15× | ||
| Q3 24 | 2.39× | 1.78× | ||
| Q2 24 | 2.18× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
FHN
| Commercial Consumer And Wealth Segment | $776.0M | 87% |
| Other | $88.0M | 10% |
| Corporate | $24.0M | 3% |
